Pomerantz Launches Securities Investigation Into First Citizens BancShares

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Pomerantz investigates First Citizens BancShares for potential securities fraud following disappointing Q4 earnings and weak guidance, triggering an 8.49% stock decline.

Pomerantz Launches Securities Investigation Into First Citizens BancShares

Pomerantz LLP has initiated an investigation into potential securities fraud claims against First Citizens BancShares, Inc. (FCNCA) following the company's fourth-quarter 2025 earnings report. The investigation centers on allegations that the bank may have misrepresented or failed to disclose material information regarding its financial performance and operational efficiency to investors.

First Citizens BancShares reported an efficiency ratio of 64.5% for Q4 2025, falling short of analyst expectations and signaling higher-than-anticipated operating costs relative to revenue generation. Additionally, the company issued a weaker-than-expected outlook for future revenue and net interest income, citing challenging operating conditions. The disappointing guidance prompted a sharp market reaction, with the stock declining 8.49% following the announcement.

Investors who purchased FCNCA shares during the relevant period and sustained losses are encouraged to contact the firm. Such investigations are typically initiated when significant earnings misses or guidance cuts raise questions about the timeliness and accuracy of prior disclosures made to the investment community.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP